Is Asparagopsis Feed Additive Approved in the EU?

Kenan KingKenan King
3 min read

The global agricultural sector is actively searching for effective, science-backed solutions to lower greenhouse gas emissions—especially methane, a potent byproduct of enteric fermentation in ruminants. Among the most promising natural interventions is Asparagopsis taxiformis, a red seaweed proven to reduce methane emissions in livestock by up to 80%.

But is it approved for commercial use? In this post, we explore the current regulatory status of Asparagopsis-based feed additives, particularly in the European Union (EU), and what this means for feed manufacturers, dairy producers, and research institutions.


The Regulatory Landscape in the EU

As of now, Asparagopsis taxiformis is not yet authorized as a feed additive across the EU, but the path toward approval is clearly underway.

Why the Delay?

The EU feed additive market is governed by Regulation (EC) No 1831/2003, which requires thorough safety and efficacy evaluations by the European Food Safety Authority (EFSA) before any novel ingredient can be added to feed on a commercial scale.

Currently, several companies—including those working with the ShiLai™ formulation—have submitted applications for authorization. These applications must demonstrate:

  • Animal safety

  • Environmental impact

  • Consumer residue safety

  • Nutritional benefit or technological function

The EFSA has begun reviewing data on Asparagopsis taxiformis, and initial feedback appears cautiously optimistic. In fact, EFSA’s scientific panel has acknowledged the seaweed’s methane-reducing mechanism, while calling for further toxicological and residue testing to support large-scale authorization.


What’s Happening Outside the EU?

While the EU is taking a more conservative, safety-first approach, other regions have moved more quickly:

  • Australia has approved Asparagopsis under voluntary and pilot feed programs.

  • New Zealand allows limited inclusion via on-farm research.

  • California and several U.S. states have greenlit commercial use under Generally Recognized As Safe (GRAS) frameworks.

  • Chile, Brazil, and South Africa are testing production and feeding programs for fast-track approval.

These regulatory green lights elsewhere are helping generate more efficacy and safety data, some of which may support the EU case.


Implications for EU Feed Producers and Researchers

For feed mills and dairy producers based in Europe, now is the time to prepare for integration, not wait passively.

Strategic Moves:

  • 🔬 Partner with producers like ShiLai™ to access EU-compliant formulations for pilot trials.

  • 🧪 Join research consortia focused on proving animal and food-chain safety.

  • 📊 Start life-cycle modeling now, using Asparagopsis impact data to prepare sustainability reporting ahead of policy shifts.

  • 🔎 Monitor EFSA and European Commission communications—authorization can be granted at any time once data thresholds are met.


ShiLai™: Leading the Regulatory Journey

ShiLai™ is one of the few producers globally with industrial-scale output (>5,000 tons), robust traceability systems, and product purity levels aligned with EFSA safety expectations.

Through joint ventures with academic labs and regulatory consultants, ShiLai™ is not only supplying Asparagopsis but actively supporting the regulatory dossier process for the EU and beyond.


Final Thoughts: Approval Is a Matter of “When,” Not “If”

The methane-mitigation potential of Asparagopsis taxiformis is too significant to ignore. While EU regulations take time, the scientific and commercial momentum is undeniable. Once authorized, this natural feed additive could become a standard ingredient in sustainable ruminant nutrition across Europe.

Forward-looking feed producers and ag researchers should act now—to stay ahead when the inevitable approval lands.

🌍 Learn more about ShiLai™'s regulatory updates and feed-ready formulations at:
🔗 https://asparagopsistaxiformisfeed.com/

0
Subscribe to my newsletter

Read articles from Kenan King directly inside your inbox. Subscribe to the newsletter, and don't miss out.

Written by

Kenan King
Kenan King